https://www.selleckchem.com/products/ml141.html
163 with CI (3.432, 36.306) and p 0.001] and deoxy-sphingosine [exp( 8.486 with CI (3.437, 20.949) and p 0.001]. There was no association between these deoxy-sphingolipids and activity of the steatohepatitis, nor was there any association with fibrosis. Differences in deoxy-sphingolipids also correlated independently with the presence of the metabolic syndrome, but not diabetes. Deoxy-sphingolipids are elevated in patients with steatosis compared to those without fatty liver, but not different between the different NAFLD subty
Like
Comment
Share
